A kind of pharmaceutical composition for treating chronic mastitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for chronic mastitis and composition, applied in the field of medicine, can solve problems such as difficult to dissipate, lingering disease, prolonged non-healing and the like, and achieve the effects of reasonable prescription, exact curative effect and low price
Inactive Publication Date: 2016-03-23
杨明
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The disease is generally not easy to purulent, ulcerated, and difficult to dissipate. However, when the patient's resistance is reduced, the original lesion may relapse acutely, resulting in pus, which makes the disease lingering and unhealed for a long time.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
experiment example
[0015] normal information
[0016] A total of 38 patients who visited our hospital from March 2012 to November 2013 were collected, all of them were female, aged 23-33 years, 33 cases were primiparas, 5 cases were multiparas, and 18 cases occurred one month after delivery , 8 cases occurred in the lactation period, 12 cases occurred in the weaning period, the shortest course was 1 month, and the longest was 6 months. 29 cases were single and 9 cases were multiple. The smallest diameter of the mass is 1.5cm, and the largest is 4cm.
[0017] Diagnostic criteria
[0018] Based on "Practical TCM Breast Diseases" (Lu Deming. Practical TCM Breast Diseases. Shanghai: Shanghai Traditional Chinese Medicine Human Science Publishing House. 196.176-178): ① The patient is a lactating woman, ② has a history of acute mastitis; ③ has A history of using a large amount of antibiotics or traditional Chinese medicine for clearing away heat and detoxification, or history of incision and drainag...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicinal composition for treating chronic mastitis. The medicinal composition is prepared from the following bulk medicaments in parts by weight: 150 parts of viburnum cylindricum leaf, 150 parts of officinal asparagus root, 90 parts of bottlebrush orchid, 80 parts of grosvener siraitia, 100 parts of purslane speedwell herb, 90 parts of asystasiella neesiana, 100 parts of scurrula limprichtii, 100 parts of hydnocarpus, 90 parts of west china hypericum, 80 parts of honeysuckle flower, 150 parts of mountain peanut, 60 parts of American ginseng, 100 parts of purple lythrum herb, 150 parts of horseweed herb, 90 parts of crab grass, 60 parts of polygonum criopolitanum, 60 parts of pedicularis resupinata, 100 parts of radix rehmanniae proparate, 100 parts of indigofera tinctoria, 60 parts of dendrobium lindleyi, 90 parts of ford manglietia fruit, 90 parts of smilax, 50 parts of evening primrose, 80 parts of ephedra herb, 60 parts of saxifraga unguiculata, 50 parts of cassia bark, 90 parts of white mustard seeds, 100 parts of common adenostema herb, 150 parts of tarenna, 90 parts of ligustrum quihoui and 90 parts of reboulia hemisphaerica. The medicinal composition for treating chronic mastitis, disclosed by the invention, is reasonable in prescription, has the characteristics of definite curative effect, safety, convenience and low cost, and does not have toxic or side effects.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating chronic mastitis. Background technique [0002] Chronic mastitis refers to a chronic protracted inflammation of the breast formed by residual inflammatory nodules or masses in the mammary gland or milk duct after acute mastitis. Clinically, it is characterized by breast agglomeration, firmness, constant skin color, and recurrent episodes, commonly known as "stiffness". The disease is generally not easy to purulent, ulcerated, and difficult to dissipate. However, when the patient's resistance is reduced, the original lesion may relapse acutely, resulting in pus, making the condition lingering and persistent. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition for treating chronic mastitis. [0004] In order to achieve the object of the present invention, the present invention provide...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more